Plan fewer, smaller portions, spaced throughout the day
Retatrutide is a synthetic triple-agonist peptide that activates GLP-1, GIP, and glucagon receptors simultaneously
The GLP-1 agonist group had significantly lower risk of heart failure (at 7 years, HR, 0.721
No major trials have tested GLP-1s in healthy people with a normal or low BMI, so its unclear how much weight such people might lose on the drug
For weight management , non-pharmacological approaches are strongly recommended: Dietary modification : Working with a registered dietitian to develop a balanced eating plan that maintains adequate nutrition for milk production Physical activity : Gradual return to exercise as appropriate postpartum Behavioural support : Structured weight management programmes that address lifestyle factors Breastfeeding itself supports metabolic health and gradual postpartum weight loss
Severe sepsis and cardiac arrhythmias